University Hospitals Birmingham NHS Foundation Trust

Chapters

StatusDrug nameNICE TAsComments
Status: RedAcetylcysteine tablets

On consultant advice only

Status: RedAmoxicillin nebulised

Hospital only

Status: RedAmphotericin (Fungizone)

Hospital only

Status: AmberAzathioprine

To be administered in conjunction with prednisolone (plain tablets). Supported by ESCA.

Status: AmberAzithromycin tablets

RICaD

Status: GreenCarbocisteine
Status: RedCeftazidime nebulised

Hospital only

Status: RedCefuroxime nebulised

Hospital only

Status: AmberColistimethate sodium

Amber: Existing patients (initiated prior to April 2013)
Promixin® - Powder for nebuliser solution
Colomycin® Injection may be used for nebulisation; administer required dose in 2-4 mL of sodium chloride 0.9%, (or water for injections) or a 1:1 mixture of sodium chloride 0.9% and water for injection
Colobreathe® - Dry powder for inhalation, hard capsule (NICE TA276)

Status: RedColistimethate sodium (Colomycin® inhalation)

Paediatric non-CF patients

Status: RedColistimethate sodium

NHS England commissioned for cystic fibrosis only. Red for new patients.

Status: AmberColomycin nebulised

NHS England Commissioned for Cystic Fibrosis only. Existing patients - initiated prior to April 2013

Status: RedColomycin nebulised

NHS England Commissioned for Cystic Fibrosis only, new patients 

Status: RedDornase alpha nebuliser solution (Pulmozyme)
Status: AmberDornase alpha nebuliser solution (Pulmozyme)

NHS England commissioned for cystic fibrosis only

Status: RedErdosteine (Erdotin)

Hospital only

Status: RedGentamicin nebulised

Hospital only

Status: RedMannitol inhalation (Bronchitol®)

Hospital only

Status: RedMeropenem nebulised

Hospital only

Status: AmberMethotrexate

ILD - ESCA

Status: RedN-Acetylcysteine nebulised
Status: GreenNebulised hypertonic sodium chloride (Resp-Ease)

Resp-Ease (Sodium Chloride 7% nebuliser solution) for CF patients

Status: RedPirfenidone

Hospital only

Status: RedPrednisolone

Plain tablets

Status: AmberTobramycin nebulised

NHS England Commissioned for Cystic Fibrosis only. Existing patients - initiated prior to April 2013

Status: RedTobramycin nebulised

NHS England Commissioned for Cystic Fibrosis only, new patients

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top